title: Different effect of propranolol and verapamil on isoprenaline-induced changes in the chick embryonic heart.
abstract: Isoprenaline (IPRO) has been reported to cause pathological lesions of the embryonic heart. The purpose of the present study was to ascertain whether the development of IPRO-induced changes can be reduced--similarly as in adults--by beta blockade or calcium antagonists. IPRO was administered to 10-day-old chick embryos intraamnially (i.a.) in a dose of 2 X 10 mg.kg-1 per 48 h; propranolol (Inderal) and verapamil (Isoptin) were injected i.a. in a dose of 1.0 or 10.0 mg.kg-1 before each injection of IPRO. It was found that propranolol completely blocked the cardiac IPRO-induced changes, i.e. cardiomegaly, avascular areas and elevation of cAMP. On the other hand, verapamil was found to have no protective effect in any dose used. Furthermore, it increased the mortality of experimental embryos. This fact support the hypothesis that cardiac sensitivity to calcium antagonists may differ during prenatal development.
authors.affiliation: Institute of Physiology, Czechoslovak Academy of Sciences, Prague.
authors.forename: B
authors.initials: B
authors.lastname: Ostádal
authors.forename: T
authors.initials: T
authors.lastname: Janatová
authors.forename: E G
authors.initials: EG
authors.lastname: Krause
authors.forename: V
authors.initials: V
authors.lastname: Pelouch
authors.forename: J
authors.initials: J
authors.lastname: Dusek
mesh_terms: D000818:Animals; D002642:Chick Embryo; D003330:Coronary Vessel Anomalies / Q000517:prevention & control; D000242:Cyclic AMP / Q000378:metabolism; D006321:Heart / Q000187:drug effects* / Q000196:embryology; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology*
chemical_list: D011433:Propranolol; D014700:Verapamil; D000242:Cyclic AMP; D007545:Isoproterenol